(Summary description)Dysregulated immune response is the key driver of pathogenesis of inflammatory bowel disease (IBD). The GI@Immu Group conducts basic and translational research...
(Summary description)Dysregulated immune response is the key driver of pathogenesis of inflammatory bowel disease (IBD). The GI@Immu Group conducts basic and translational research...
Dysregulated immune response is the key driver of pathogenesis of inflammatory bowel disease (IBD). The GI@Immu Group conducts basic and translational research that aims at understanding the function of the immune cell and underlying immunoregulatory mechanism in IBD. Our goal is to identify and develop novel immuno-modulatory targets from Chinese Herbal Medicine for IBD management.
Centre for Chinese Herbal Medicine Drug Development Limited
Units 201-207, Building 15W, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong
©2021 Centre for Chinese Herbal Medicine Drug Development Limited
